52 people exhibit adverse events after receiving COVID vaccine in Delhi

New Delhi [India], January 16 (ANI): The total number of Adverse events following immunisation (AEFI) post-COVID-19 vaccine in Delhi stands at 52 out of which only one is severe, said the Delhi Government on Saturday.
North Delhi has reported one minor AEFI case while South East Delhi and North West Delhi have reported 5 and 4 AEFI cases respectively.
East Delhi reported 6 cases, Central Delhi 2, South Delhi 11 minor AEFI cases and one severe case, New Delhi 5, South West Delhi 11 and West Delhi reported 6 AEFI cases.
At least 4,319 healthcare workers received COVID-19 shot against the target of 8,117. The vaccination was held at 81 sites in the national capital, said Delhi Government.
Two healthcare workers who received the COVID-19 vaccine at NDMC's Charak Palika Hospital, Delhi faced mild adverse event post-vaccination, said New Delhi Municipal Council (NDMC) official today.
They suffered mild tightness in the chest. They were kept under observation by the AEFI team and were discharged after 30 minutes when they felt normal.
"Both the healthcare beneficiaries were female paramedics posted at our hospital," an NDMC official confirmed ANI requesting anonymity.
"Our Charak Palika hospital was provided with Covishield vaccines. About 43 healthcare beneficiaries reported to the centre and received the vaccine shot," the official added.
The Charak Palika Hospital (CPH), based in Moti Bagh, is one of the designated hospitals for the dissemination of the vaccine, out of the seven hospitals in the New Delhi district and 81 hospitals in Delhi City.
At least 1,91,181 healthcare beneficiaries received Covid-19 jab on Saturday across India, marking it as a historic and biggest COVID-19 vaccination drive launched by Prime Minister Narendra Modi.
"No case of post-vaccination hospitalisation has been reported so far," said the union health ministry. About 16,755 total vaccinators were involved across India during the COVID vaccination drive, it said. (ANI)